- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06620315
Comparison Between Primary and Secondary Implant Stability of Hybrid Versus Resorbable Blast Media (RBM) Surfaces Using Resonance Frequency Analysis (IMPLANTSTABIL)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
An approval from the hospital ethical committee will be obtained for this study. As a protocol all patients presenting to Institute of Dentistry, CMH Lahore Medical College will be examined in general OPD and those patients who fulfill the inclusion and exclusion criteria will be referred to Prosthodontics department. After history, complete oral examination and informed consent. Patients will be divided into two groups by lottery method; In Group 1 Hybrid (sand blasted acid etched implants) will be place. In Group 2 Resorbable Blast Media (RBM) implant surfaces will be placed. On the basis of randomized study the patients will be selected for the study to measure implant primary stability with a resonance frequency analyzer at the time of initial loading of implant, starting with an assessment immediately following implant placement with insertion torque of 30 Ncm and then secondary stability at 12 weeks post operatively by using Ostell Mentor. This instrument on each implant by inserting a standardized abutment (Smartpeg) of fixed length into each implant. The transducer probe (Osstell mentor probe) will be held so that the probe tip was aimed at the small magnet on top of the Smartpeg at a distance of 2-3 mm in both the buccal and lingual directions, and the mean of these measurements will then be calculated. The probe will be held still during the pulsing time until the instrument beeped and the displayed the ISQ value. ISQ1 will be evaluated immediately during initial implant loading which will be primary stability and ISQ2 will be evaluated after 12 weeks of implant placement when implant is properly osseointegrated, which will be secondary stability of an implant.
The implant fixtures will be DIO UF II for the Hybrid implants and the Osstem TSII plus system for the RBM implants. Data would be stratified for age, gender and implant site to address the effect modifiers.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Punjab
-
Lahore, Punjab, Pakistan, 41000
- Department of Prosthodontics, Institute of Dentistry/CMH Lahore Medical College.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
o Age between 20 to 50 years.
- Both male and female patients will be selected.
Patients suitable for implant restorations on CBCT will be diagnosed by;
- Bone height (minimum of 12mm)
- Bone width (minimum of 5mm)
- Proximity with vital structures (nerves, blood vessels)
Exclusion Criteria:
o Patients with diabetes, Parkinson's disease, myasthenia gravis and bulbar palsy
- Diseases with either a strong connection to emotional stress or impairing mental health like depression, anxiety, sleeping disorder on history examination.
- Patients with poor oral hygiene.
- Patients with parafunctional habits of severe clenching habit, bruxism.
- Heavy smokers
- Patients who had undergone radiotherapy or chemotherapy.
- Patients with osteoarthritis, osteoporosis.
- Patients taking bisphosphonates
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Hybrid (sand blasted acid etched implants)
|
sand blasted implant
|
|
Active Comparator: RBM
RBM implant
|
Resorbable Blast Media (RBM) implant surfaces can enhance osseointegration and implant stability
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Primary Stability
Time Frame: up to 3 months
|
absence of clinically detectable implant mobility
|
up to 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Secondary Stability
Time Frame: 3 months
|
absence of clinically detectable implant mobility
|
3 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CPSP/REU/DSG-2018-262-2439
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Implant Complication
-
University of BelgradeCompleted
-
Kafrelsheikh UniversityCompletedDental Implant Failed | Implant ComplicationEgypt
-
National Research Centre, EgyptCompletedImplant Complication | Implant Site ReactionEgypt
-
Fondazione Policlinico Universitario Agostino Gemelli...CompletedImplant ComplicationItaly
-
George Eastman Dental Hospital, ItalyCompleted
-
Postgraduate Institute of Dental Sciences RohtakCompleted
-
Harvard Medical School (HMS and HSDM)Recruiting
-
Harvard Medical School (HMS and HSDM)Active, not recruitingImplant ComplicationUnited States
-
Cairo UniversityActive, not recruiting
-
Mansoura UniversityCompletedImplant ComplicationEgypt
Clinical Trials on sand blasted implant
-
Vastra Gotaland RegionUnknownEndosseous Dental Implant FailureSweden
-
University of ManoubaCompleted
-
Majmaah UniversityUnknownChronic StrokeSaudi Arabia
-
University of HelsinkiTampere UniversityCompletedImmune System Diseases | Atopic DisordersFinland
-
Eskisehir Osmangazi UniversityCompletedClinical Nursing ResearchTurkey
-
Riphah International UniversityRecruitingAutism Spectrum DisorderPakistan
-
Ondokuz Mayıs UniversityCompletedTHE EFFECT OF SANDPLAY THERAPY ON THE ANXİETY AND PAİN LEVELS OF CHİLDREN DURİNG PREOPERATİVE PERİODPostoperative Pain | Preoperative Anxiety | TonsillectomyTurkey (Türkiye)
-
University of YorkMedical Research CouncilCompletedLeishmaniasis, Cutaneous | Insect BitesUnited Kingdom
-
October University for Modern Sciences and ArtsCompletedTooth Loss | Dental Implant | Jaw, Edentulous, Partially | Molar TeethEgypt
-
Riphah International UniversityCompleted